Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma

Little is known about the impact of multiple myeloma (MM) treatment on uninvolved immunoglobulins (Ig). We identified 448 patients who received high-dose dexamethasone (HD-DEX), lenalidomide and dexamethasone (RD), bortezomib and dexamethasone (VD), bortezomib, cyclophosphamide and dexamethasone (VC...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Blood Cancer J
Huvudupphovsmän: Ravi, P, Kumar, S, Gonsalves, W, Buadi, F, Lacy, M Q, Go, R S, Dispenzieri, A, Kapoor, P, Lust, J A, Dingli, D, Lin, Y, Russell, S J, Leung, N, Gertz, M A, Kyle, R A, Bergsagel, P L, Rajkumar, S V
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2017
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5584483/
https://ncbi.nlm.nih.gov/pubmed/28622306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2017.46
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk